01
Basic Science
Molecular markers, methylation classification, and the cellular and immune microenvironment driving meningioma biology.
28 September 2026 Rome, Italy
Meningioma Symposium
2026
Basic Science · Translation · Clinics
Officially endorsed by
About the symposium
One day. One disease. Three perspectives.
A focused, single-track meeting bringing together international leaders in meningioma research and clinical care — bridging molecular biology, translational science, and clinical practice.
02
Translation
Preclinical models, host factors, and biomarker-guided strategies that move discoveries from the bench toward patients.
03
Clinics
Surgical innovation, radiation, systemic options, and integrated treatment paradigms shaping contemporary meningioma management.
Programme · 28 September 2026
Five sessions. Ten international speakers.
A single-track day designed for depth and discussion. Each session pairs invited talks with selected abstract presentations and an open roundtable.
-
01 09:00 — 10:30
Molecular Markers
Arie Perry San Francisco · Wenya Linda Bi Boston · Felix Sahm Heidelberg
+ selected abstract presentations
Spatial multi-omic profiling of meningiomas identify conserved patterns of cellular interactions associated with malignancy Yiheng Tang
Spatial organization of macrophage activation programs defines prognostic niches in meningioma Domenico Calafato
An epigenetic neoplastic and stromal DNA-signature continuum refines subtyping in meningioma and identifies risk-predication potential for immune-cell counts Sybren Maas
Meningiomas from pediatric patients and young adults constitute molecularly distinct entities not captured by adult-based risk strategies Natalie Berghaus
Prognostic impact of tumour-infiltrating lymphocytes in atypical meningioma Massimiliano Del Bene
Distinct Copy Number Variation (CNV)-associated epigenetic signatures underlie prognostic heterogeneity in Brain-Invasive Otherwise-Benign (BIOB) meningiomas Alessia Ricci
-
02 10:45 — 12:00
Treatment
Jennifer Moliterno New Haven · Murat Günel New Haven
+ selected abstract presentations
[177Lu]Lu-DOTATATE in recurrent meningioma response, dosimetry and correlations with uptake in pretherapeutic somatostatin receptor PET Maximilian Mair
Epigenetic silencing of clustered protocadherins contributes to meningioma progression Daniel Merk
A multicenter, randomized phase II trial of regorafenib for recurrent meningioma: the MIRAGE trial Alberto Bosio
- 12:00 — 13:00 Lunch & networking
-
03 13:00 — 14:20
Models
Matthieu Peyre Paris · Rolf Warta Heidelberg · David Raleigh San Francisco
-
04 14:30 — 15:30
Host Factors
Jonathan Kipnis St. Louis · Christian Mawrin Magdeburg
-
05 15:30 — 16:00
Roundtable & Concluding Remarks
Moderated by Michel Kalamarides
Faculty
International speakers
Confirmed faculty from leading centres in Europe and North America. Further speakers to be announced.
Arie Perry
San Francisco
Molecular Markers
Wenya Linda Bi
Boston
Molecular Markers
Felix Sahm
Heidelberg
Molecular Markers
Jennifer Moliterno
New Haven
Treatment
Murat Günel
New Haven
Treatment
Matthieu Peyre
Paris
Models
Rolf Warta
Heidelberg
Models
David Raleigh
San Francisco
Models
Jonathan Kipnis
St. Louis
Host Factors
Christian Mawrin
Magdeburg
Host Factors
Michel Kalamarides
Paris
Roundtable ModeratorSubmissions & updates
Where we are right now
A quick snapshot of the most relevant submission and programme updates ahead of the meeting.
Registration
Registration is now open. Secure your place at the symposium here.
Late-breaking abstracts
The late-breaking abstract submission deadline has passed. Presenters of accepted abstracts have already been informed of their acceptance.
Regular abstract submission
The regular call for abstracts has closed. Presenters of accepted abstracts have already been informed of their acceptance.
Convene where antiquity meets modern science.
The symposium takes place on Isola Tiberina — the small island in the Tiber at the heart of Rome, a place dedicated to medicine and healing since antiquity.
Participants are encouraged to plan their travel early to make the most of the day in Rome and the surrounding academic community.
- Date
- Monday, 28 September 2026
- Venue
- Isola Tiberina, Rome
- Format
- Single-track in-person meeting
- Language
- English
Join us in Rome.
Registration is now open. Secure your place at the symposium.
Register nowEarly registration until 12 August 2026
| Category | Fee (EUR, incl. 22% VAT) |
|---|---|
| Regular | EUR 250 |
| EANO / SNO Member | EUR 125 |
| Nurse / AHP regular | EUR 80 |
| Nurse / AHP EANO / SNO Member | EUR 40 |
| PhD Student / Resident / Trainee regular | EUR 80 |
| PhD Student / Resident / Trainee EANO / SNO Member | EUR 40 |
| Industry representative | EUR 700 |
Late / Onsite registration after 12 August 2026
| Category | Fee (EUR, incl. 22% VAT) |
|---|---|
| Regular | EUR 550 |
| EANO / SNO Member | EUR 275 |
| Nurse / AHP regular | EUR 160 |
| Nurse / AHP EANO / SNO Member | EUR 80 |
| PhD Student / Resident / Trainee regular | EUR 160 |
| PhD Student / Resident / Trainee EANO / SNO Member | EUR 80 |
| Industry representative | EUR 900 |
Included in the registration fee
- Access to all scientific sessions
- 2 coffee breaks
- Light lunch
Member rates
Members of EANO (European Association of Neuro-Oncology) and SNO (Society for Neuro-Oncology) are eligible for the reduced member rate.
Cancellation policy
- Written cancellation until 12 August 2026: 25% refund
- After 12 August 2026: no refund
- No refund for no-shows or early departure
Cancellations must be submitted in writing to meningiomasymposium@wma.co.at. Consumers have the right to withdraw within 14 days of registration, provided access to the conference has not yet been requested.
Payment
- All fees in EUR
- Credit card: Visa, Mastercard, American Express
- Bank transfer (until 11 September 2026) — all transfer fees to be borne by the sender
We thank our valued partners for their support.
